成立年份: 2013
总资产(USD): 不愿意公开
员工总人数: 80至89
主要竞争优势: 品牌,国际认证/标准,经验丰富的研发人员,发货速度,生产能力,产品线丰富,合同定制,接受买家的规格要求,接受小额订单,良好的信誉,优质服务
其他竞争优势:
专利与版权:
业务类型: 制造商
年销售额(USD): 不愿意公开
主要销售市场: 北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
主要产品类别: 原料药,中间体,生物制品,天然提取物,药用辅料,食品添加剂,饲料添加剂
所有产品: Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.
外销比重:
内销比重:
主要客户:
合同定制:
付款条款:
In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.
In 2008, We passed ISO quality system certificate
In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.
In 2016, obtain a registered trademark “ BJM ”.
In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate(DL-HOMO). At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.
In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.
In 2020, we registered BJM Pharm Yunmeng Co., Ltd, and the new production base settled in Geputan chemical park with a total area of 50000 square meters.
武汉东湖高新区光谷大道41号